title: Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone.
abstract: Gonadotrophin surge-attenuating factor (GnSAF) is a putative non-steroidal ovarian factor which attenuates the luteinizing hormone (LH) surge in superovulated women through the reduction of the pituitary response to gonadotrophin-releasing hormone (GnRH). The mechanism of action of GnSAF on gonadotrophin secretion was further studied by investigating six normally ovulating women in two cycles--a spontaneous and a follicle-stimulating hormone (FSH)-treated cycle. The response of the pituitary to five consecutive pulses of GnRH was investigated in late follicular phase (follicle size 15 mm) of both cycles. GnRH pulses, 10 micrograms each, were injected i.v. every 2 h and LH was measured in blood samples taken before and 30, 60 and 120 min after each pulse. FSH was injected daily at the fixed dose of 225 IU starting on cycle day 2. Peak values of LH increment occurred 30 min after each pulse. However, maximal LH increment occurred in both cycles after the second GnRH dose. In the FSH cycles the response of LH to the first three pulses was significantly attenuated compared with the spontaneous cycles, while the response to the fourth and fifth pulses was similar in the two cycles. In both cycles, LH increment 30 min post GnRH (net increase above the previous value) was similar after the fourth and fifth pulses. Serum concentrations of oestradiol and immunoreactive inhibin, although higher in the FSH cycles, remained stable throughout the GnRH experimental period in both cycles. These results demonstrate that multiple submaximal doses of GnRH can override the attenuating effect of GnSAF on LH secretion.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Obstetrics and Gynaecology, University of Ioannina, Greece.
authors.forename: I E
authors.initials: IE
authors.lastname: Messinis
authors.forename: D
authors.initials: D
authors.lastname: Lolis
authors.forename: K
authors.initials: K
authors.lastname: Zikopoulos
authors.forename: E
authors.initials: E
authors.lastname: Tsahalina
authors.forename: K
authors.initials: K
authors.lastname: Seferiadis
authors.forename: A A
authors.initials: AA
authors.lastname: Templeton
mesh_terms: D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000494:pharmacology; D005498:Follicular Phase; D042341:Gonadal Hormones; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007265:Inhibins / Q000097:blood; D007700:Kinetics; D007986:Luteinizing Hormone / Q000378:metabolism*; D006080:Ovarian Follicle / Q000033:anatomy & histology / Q000502:physiology; D011506:Proteins; D013480:Superovulation
chemical_list: D042341:Gonadal Hormones; D011506:Proteins; C080538:attenuin; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D007265:Inhibins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone